Many current inhalers for conditions such as asthma contain propellants that are potent greenhouse gases. A study from researchers at the ̽»¨Ö±²¥ of Cambridge has found that switching to alternative, greener inhalers would not only result in large carbon savings, but could be achieved alongside reduced drug costs by using less expensive brands.